The store will not work correctly when cookies are disabled.
(E)-4-(4-chlorophenyl)-1-((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)but-3-en-2-one
ID: ALA551762
PubChem CID: 45272309
Max Phase: Preclinical
Molecular Formula: C15H17ClO5
Molecular Weight: 312.75
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(/C=C/c1ccc(Cl)cc1)C[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O
Standard InChI: InChI=1S/C15H17ClO5/c16-10-4-1-9(2-5-10)3-6-11(17)7-13-15(20)14(19)12(18)8-21-13/h1-6,12-15,18-20H,7-8H2/b6-3+/t12-,13+,14+,15+/m1/s1
Standard InChI Key: ONSPIITXJAAAAE-WTSOPZKSSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
-1.6380 -4.9906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9263 -5.4031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2104 -4.9906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5013 -5.4031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9263 -6.2281 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.3539 -5.4031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3539 -6.2281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6380 -6.6406 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.0697 -6.6406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0697 -7.4656 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.7856 -6.2281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4973 -6.6406 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.7856 -5.4031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0697 -4.9906 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2132 -4.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9277 -5.3876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6384 -4.9701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6323 -4.1443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9095 -3.7376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2018 -4.1575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3429 -3.7252 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
7 9 1 0
9 10 1 1
9 11 1 0
11 12 1 6
11 13 1 0
13 14 1 0
6 14 1 0
6 1 1 1
4 15 1 0
1 2 1 0
15 16 2 0
2 3 1 0
16 17 1 0
3 4 2 0
17 18 2 0
2 5 2 0
18 19 1 0
6 7 1 0
19 20 2 0
20 15 1 0
7 8 1 6
18 21 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 312.75 | Molecular Weight (Monoisotopic): 312.0765 | AlogP: 0.79 | #Rotatable Bonds: 4 |
Polar Surface Area: 86.99 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.69 | CX Basic pKa: ┄ | CX LogP: 1.13 | CX LogD: 1.13 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.72 | Np Likeness Score: 1.19 |
References
1. Bisht SS, Fatima S, Tamrakar AK, Rahuja N, Jaiswal N, Srivastava AK, Tripathi RP.. (2009) Synthetic studies in butenonyl C-glycosides: Preparation of polyfunctional alkanonyl glycosides and their enzyme inhibitory activity., 19 (10): [PMID:19362832] [10.1016/j.bmcl.2009.03.136] |